ZDHHC3 further exhibited promoted effects on NASH progression by activating IRHOM2 and its downstream MAP3K7‐JNK cascade signaling, thereby increasing hepatosteatosis, inflammation, and collagen accumulation. This evidence concerns the gene ZDHHC3 and metabolic dysfunction-associated steatohepatitis.